BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23905674)

  • 1. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination.
    Hegazy N; Pötter R; Kirisits C; Berger D; Federico M; Sturdza A; Nesvacil N
    Acta Oncol; 2013 Oct; 52(7):1345-52. PubMed ID: 23905674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
    Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
    Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
    Swanick CW; Castle KO; Vedam S; Munsell MF; Turner LM; Rauch GM; Jhingran A; Eifel PJ; Klopp AH
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):793-800. PubMed ID: 27788952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
    Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
    Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
    Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours.
    Viswanathan AN; Dimopoulos J; Kirisits C; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):491-8. PubMed ID: 17331668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
    Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
    Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy.
    Okazaki S; Murata K; Noda SE; Kumazaki Y; Hirai R; Igari M; Abe T; Komatsu S; Nakano T; Kato S
    J Radiat Res; 2019 Jul; 60(4):490-500. PubMed ID: 31111896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical feasibility of MR-assisted CT-based cervical brachytherapy using MR-to-CT deformable image registration.
    Dyer BA; Yuan Z; Qiu J; Shi L; Wright C; Benedict SH; Valicenti R; Mayadev JS; Rong Y
    Brachytherapy; 2020; 19(4):447-456. PubMed ID: 32327343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of MRI deformable image registration for CT-based brachytherapy in locally advanced cervical cancer.
    Tait LM; Hoffman D; Benedict S; Valicenti R; Mayadev JS
    Brachytherapy; 2016; 15(3):333-340. PubMed ID: 26882845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
    Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
    Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
    Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
    Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy: A systematic review.
    Wang F; Tang Q; Lv G; Zhao F; Jiang X; Zhu X; Li X; Yan S
    Brachytherapy; 2017; 16(2):353-365. PubMed ID: 27965118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO).
    Iwai Y; Nemoto MW; Horikoshi T; Kanazawa A; Kurokawa M; Saito M; Harada R; Kobayashi H; Uno T
    Jpn J Radiol; 2020 Sep; 38(9):899-905. PubMed ID: 32333219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
    Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
    Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study.
    Petrič P; Hudej R; Rogelj P; Blas M; Tanderup K; Fidarova E; Kirisits C; Berger D; Dimopoulos JC; Pötter R; Hellebust TP
    Radiother Oncol; 2013 Apr; 107(1):6-12. PubMed ID: 23453539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
    Pötter R; Federico M; Sturdza A; Fotina I; Hegazy N; Schmid M; Kirisits C; Nesvacil N
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):588-97. PubMed ID: 26867887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.
    Viswanathan AN; Erickson B; Gaffney DK; Beriwal S; Bhatia SK; Lee Burnett O; D'Souza DP; Patil N; Haddock MG; Jhingran A; Jones EL; Kunos CA; Lee LJ; Lin LL; Mayr NA; Petersen I; Petric P; Portelance L; Small W; Strauss JB; Townamchai K; Wolfson AH; Yashar CM; Bosch W
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):320-8. PubMed ID: 25304792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.